Intravenous methylprednisolone with or without tocilizumab in patients with severe COVID-19 pneumonia requiring oxygen support: A prospective comparison

• Hoofdauteurs: Dujana Mostafa Hamed (Auteur), Khawla Mohammad Belhoul (Auteur), Naama Abdelrahman Al Maazmi (Auteur), Farah Ghayoor (Auteur), Muneeba Moin (Auteur), Mahra Al Suwaidi (Auteur), Meeruna Narainen (Auteur), Maryam Makki (Auteur), Mahera AbdulRahman (Auteur)
• Formaat: Boek
• Gepubliceerd in: Elsevier, 2021-08-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Background: Cytokine storm is a marker of severity and severe mortality in patients with coronavirus disease 2019 (COVID-19) pneumonia. Immunomodulatory treatments may reduce morbidity and mortality. Objectives: To determine whether a 7-day course of methylprednisolone (MP) administered with and wit...